Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bratisl Lek Listy ; 115(7): 395-9, 2014.
Article in English | MEDLINE | ID: mdl-25077360

ABSTRACT

OBJECTIVE: One of the reasons of bacterial translocation (BT) is the complete or partial intestinal obstructions (PIO) of the gastrointestinal system. In this study, we aimed to investigate the effects of recombinant human Growth Hormone (rhGH) on BT in rats with partial intestinal obstruction (PIO). MATERIAL AND METHODS: The rats were randomly divided into the 4 groups: Group I: Sham-operated (SO) (n = 12), Group II control PIO (n = 12), Group III: PIO with rhGH treatment for 5 days (n = 12), Group IV: PIO with rhGH treatment 5 days before PIO and 5 days after PIO (a total of 10 days) (n = 12). In the groups III and IV, the effects of 5 and 10 days administered rhGH were examined. RESULTS: The level of serum and of intestinal fluid IgA was significantly higher in the Group IV compared to the Group I, Group II and Group III. In the Group IV, the number of small intestinal goblet and colonic goblet cells, and the lengths of intestinal mucosal villi and crypt depths were statistically significantly higher than in Groups II and III. The rate of bacterial translocation was higher in the Group II: 100 % in MLNs, 41.6 % in blood culture and 50.8 % in the liver cultures, it was significantly higher compared to the other groups (p < 0.01). CONCLUSIONS: The study results demonstrated that administration of rhGH to the rats with PIO for at least 10 days decreased bacterial translocation (Fig. 3, Ref. 25).


Subject(s)
Bacterial Translocation/drug effects , Human Growth Hormone/pharmacology , Immunoglobulin A/blood , Intestinal Obstruction/blood , Intestinal Obstruction/drug therapy , Protective Agents/therapeutic use , Adult , Animals , Humans , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Intestinal Obstruction/microbiology , Liver/microbiology , Male , Random Allocation , Rats , Recombinant Proteins/pharmacology
2.
Indian J Pediatr ; 67(3): 163-7, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10838716

ABSTRACT

Benzathine penicillin G (BPG) is effective for secondary prophylaxis of rheumatic fever (RF). However, interval between injections a remains a controversial matter. In a study population of 74 patients, following the initial diagnosis of RF, 3-weekly BPG (1.2 million units) regimen was started. During the first three-week period, serum penicillin concentrations were examined on the 7th, 14th and 21st days and throat culture done for group-A b hemolytic streptococcal (GABHS) infection. Ten patients (13.5%) at 21st day of injection had low serum penicillin concentration after the first BPG. GABHS was isolated in 5 patients during this period. Although two of these 5 patients had symptoms of respiratory tract infection, according to laboratory data, the other three were accepted as carriers. All 74 patients were then followed-up for rheumatic recurrence (RR) during long-term period (6 to 60 months, mean 25 +/- 5 months). There was no RR among regular (missing no more than one injection a year) group. We concluded that 3-weekly BPG regimen was satisfactory for secondary prophylaxis in RF, even though serum penicillin level was inadequate during the third week in some of the patients.


Subject(s)
Penicillin G Benzathine/administration & dosage , Penicillins/administration & dosage , Rheumatic Fever/prevention & control , Adolescent , Child , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Male , Recurrence , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...